Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
If you need cash right now, there are several ways to obtain it quickly. Learn about options available to secure immediate funds.
24,959 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Three growth sectors are reshaping everyday life and attracting patient, long-term capital as markets steady in 2026....
Stocks rose Tuesday as AI momentum outweighed inflation jitters, with fresh analyst calls on Autodesk, Celanese, DexC...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
A fresh round of political headlines rattled major indices, but three forgotten micro-cap stocks under $30 surged on ...
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
Virgin Galactic stock tumbles on dilution fears tied to a settlement, while AST SpaceMobile and Planet Labs push high...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
SpaceX kicked off trading with a sharp first-day rally. This guide analyzes historical IPO patterns to estimate where...
A $1 million retirement yields similar gross income in Lexington, KY and Myrtle Beach, SC, but the long-run dollars d...
Early data from the 2026 World Cup in the U.S. shows host-city spending rising while visitor demand surges, challengi...